Takeda’s new deal with Kumquat; IL-2 biotech raises $55M
Plus, news about Neurocrine Biosciences, Nxera Pharma, Voyager Therapeutics and Acorda Therapeutics: Takeda inks pact with Kumquat: The San Diego biotech will get up to $130 million in the near term and could receive more than $1.2 billion …